BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31365694)

  • 1. Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.
    Wang Q; Liu J; Guo Y; Dong G; Zou W; Chen Z
    Braz J Med Biol Res; 2019; 52(8):e8443. PubMed ID: 31365694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF Val66Met polymorphism and cognitive impairment in Parkinson's disease-a meta-analysis.
    Yin Y; Su X; Pan L; Li C
    Neurol Sci; 2019 Sep; 40(9):1901-1907. PubMed ID: 31104169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
    Gao L; Díaz-Corrales FJ; Carrillo F; Díaz-Martín J; Caceres-Redondo MT; Carballo M; Palomino A; López-Barneo J; Mir P
    Acta Neurol Scand; 2010 Jul; 122(1):41-5. PubMed ID: 20085561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
    Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
    Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis.
    Zintzaras E; Hadjigeorgiou GM
    J Hum Genet; 2005; 50(11):560-566. PubMed ID: 16172806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the BDNF G196A and C270T polymorphisms and Parkinson's disease: a meta-analysis.
    Dai L; Wang D; Meng H; Zhang K; Fu L; Wu Y; Bai Y
    Int J Neurosci; 2013 Oct; 123(10):675-83. PubMed ID: 23611539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
    Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
    Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.
    Cagni FC; Campêlo CLDC; Coimbra DG; Barbosa MR; Júnior LGO; Neto ABS; Ribeiro AM; Júnior COG; Gomes de Andrade T; Silva RH
    J Neuropsychiatry Clin Neurosci; 2017; 29(2):142-147. PubMed ID: 27852165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Val66Met polymorphism of brain-derived neurotrophic factor is associated with idiopathic dystonia.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Clin Neurosci; 2015 Mar; 22(3):575-7. PubMed ID: 25523127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.
    Wang J; Zhang F; Zhu W; Liu Y; Zhou Z
    Acta Neuropsychiatr; 2015 Dec; 27(6):327-35. PubMed ID: 26503495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Altmann V; Schumacher-Schuh AF; Rieck M; Callegari-Jacques SM; Rieder CR; Hutz MH
    Neurosci Lett; 2016 Feb; 615():88-91. PubMed ID: 26806863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
    Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
    Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between the Brain-derived Neurotrophic Factor Val66Met Polymorphism and Overweight/Obesity in Pediatric Population.
    Martínez-Ezquerro JD; Rendón-Macías ME; Zamora-Mendoza G; Serrano-Meneses J; Rosales-Rodríguez B; Escalante-Bautista D; Rodríguez-Cruz M; Sánchez-González R; Arellano-Pineda Y; López-Alarcón M; Zampedri MC; Rosas-Vargas H
    Arch Med Res; 2017 Oct; 48(7):599-608. PubMed ID: 29506764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.
    Foltynie T; Lewis SG; Goldberg TE; Blackwell AD; Kolachana BS; Weinberger DR; Robbins TW; Barker RA
    J Neurol; 2005 Jul; 252(7):833-8. PubMed ID: 15772739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.
    Wang Z; Li Z; Gao K; Fang Y
    BMC Psychiatry; 2014 Dec; 14():366. PubMed ID: 25539739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.